i-sense continues diagnostic development during COVID-19 lockdown
In mid-March, when the UK went into lockdown, a small group of researchers were given special access to i-sense labs in London, under modified safety measures. They were tasked with the important job of working collaboratively to develop point-of-care diagnostic tests...
London Plasmonics Forum goes digital
LCN researchers at King’s, Imperial and UCL took part in the first digital London Plasmonics Forum on 11 June. The London Plasmonics Forum has been held annually at King’s College London since 2015, but in 2020 this was not possible due to COV-ID 19, so instead...
Nanomaterial solution with the potential to fight aggressive cancer
LCN Professor Julian Jones has led research into finding a nanomaterial solution which has the potential to fight aggressive breast cancer. The research highlights how Zinc-loaded particles might have the potential to fight triple-negative breast cancer, an aggressive...